Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia

被引:8
|
作者
Tan, Xinran [1 ]
Ma, Lulin [1 ]
Yuan, Jie [1 ,2 ]
Zhang, Dexin [1 ]
Wang, Jie [1 ]
Zhou, Wenjing [2 ]
Cao, Song [1 ,2 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Pain Med, 149 Dalian Rd, Zunyi 563000, Peoples R China
[2] Zunyi Med Univ, Guizhou Key Lab Anesthesia & Organ Protect, Zunyi 563000, Peoples R China
来源
JOURNAL OF PAIN RESEARCH | 2019年 / 12卷
关键词
postherpetic neuralgia; lidocaine; pain; intravenous infusion; LOCAL BRAIN ACTIVITY; HERPES-ZOSTER; SYSTEMIC LIDOCAINE; NEUROPATHIC PAIN; PREVENTION; DEPRESSION; MANAGEMENT; MECHANISMS; SAFETY;
D O I
10.2147/JPR.S213128
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Postherpetic neuralgia (PHN) is one kind of severe neuropathic pain which currently cannot be effectively cured. Recent researches suggest that intravenous infusion of lidocaine has a therapeutic effect on neuropathic pain such as PHN; however, the optimal dose and frequency of lidocaine infusion and the effectiveness and safety of this treatment in PHN patients still needs more clinical research. The aim of this study was to evaluate the therapeutic effects of daily intravenous lidocaine infusion on the outcome of the routine treatment of PHN. Methods: Sixty PHN patients were randomly divided into two groups: 1) control group (Control), treated with conventional therapies, such as antiepileptic pills, analgesics, neurotrophic medicines, paravertebral spinal nerve block and physiotherapy; 2) lidocaine group (Lido) received daily infusion of lidocaine (4 mg/kg) besides the conventional treatments. If the pain is not controlled sufficiently, additional tramadol is given and the average consumption of tramadol is calculated. Pain intensity was assessed before and after each infusion, and the number of breakthrough pain in the last 24 hrs were recorded. The incidence of adverse reactions related to intravenous lidocaine infusion was recorded. Results: For five consecutive days, numeric rating scale (NRS) scores were significantly decreased after 1 hr of intravenous infusion of lidocaine. Compared with Control, the NRS scores and the frequency of breakthrough pain in the Lido were significantly reduced. In addition, the extra tramadol consumption in the Lido was significantly lower than that in the Control, and the average hospital stay of patients in Lido was decreased. However, anxiety and depression scores showed no difference between Lido and Control. Conclusion: Daily intravenous lidocaine (4 mg/kg for 5 days) enhanced the outcome of PHN treatment, reduced the amount of analgesic medicine and shortened the length of hospital stay with no obvious adverse side effects.
引用
收藏
页码:2537 / 2545
页数:9
相关论文
共 50 条
  • [41] Treatment of postherpetic neuralgia: A review of therapeutic options
    Argoff, CE
    Katz, N
    Backonja, M
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 28 (04) : 396 - 411
  • [42] Systematic Review and Meta-analysis of the Efficacy of Oral Medications Compared with Placebo Treatment in the Management of Postherpetic Neuralgia
    Salah, Sabrina
    Thomas, Lesly
    Ram, Saravanan
    Clark, Glenn T.
    Enciso, Reyes
    JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE, 2016, 30 (03) : 255 - 266
  • [43] ZTlido - A New Lidocaine Patch for Postherpetic Neuralgia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1568): : 41 - 43
  • [44] Efficacy of CT Guided Pulsed Radiofrequency Treatment for Trigeminal Postherpetic Neuralgia
    Ding, Yuanyuan
    Hong, Tao
    Li, Hongxi
    Yao, Peng
    Zhao, Guangyi
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [45] A study on the effect of topical 5% lidocaine patches on postherpetic neuralgia
    Kim, Tack Hun
    Park, Tae Ho
    Yoo, Jae Hak
    Kim, Kea Jeung
    ANNALS OF DERMATOLOGY, 2007, 19 (01) : 1 - 8
  • [46] Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin
    Shaparin, Naum
    Slattum, Patricia W.
    Bucior, Iwona
    Nalamachu, Srinivas
    CLINICAL JOURNAL OF PAIN, 2015, 31 (11) : 983 - 991
  • [47] Acupuncture (superficial dry-needling) as a treatment for chronic postherpetic neuralgia - a randomized clinical trial
    Sollie, Martin
    Pind, Robert
    Madsen, Christoffer Bing
    Sorensen, Jens Ahm
    BRITISH JOURNAL OF PAIN, 2022, 16 (01) : 96 - 108
  • [48] The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis
    Liu, Xi
    Wei, Liling
    Zeng, Qiong
    Lin, Kun
    Zhang, Jia
    PAIN PHYSICIAN, 2020, 23 (06) : 541 - +
  • [49] Treatment of postherpetic neuralgia
    Malin, JP
    NERVENHEILKUNDE, 1998, 17 (04) : 150 - 153
  • [50] Treatment of postherpetic neuralgia
    Nurmikko T.J.
    Haanpää M.
    Current Pain and Headache Reports, 2005, 9 (3) : 161 - 167